A pioneering new drug has been clinically proven to reduce the chance of someone dying from a heart attack or stroke (WalesOnline, 2017). Following a worldwide trial involving 27,500 high risk patients, evolocumab, also known as Repatha, was found to radically lower cholesterol levels. The study, which included scientists at Swansea University, found that evolocumab … Continue reading New drug proven to reduce your risk of dying from a heart attack or stroke

The Bevan Commission Academy for Health Leadership and Innovation has been formally opened at Swansea University’s Bay Campus by Dr Andrew Goodall, Director General of NHS Wales (Swansea University, 2017). The Bevan Commission Academy responds to the findings of the Commission for stronger leadership and innovation through a more prudent approach to health and wellbeing … Continue reading Bevan Commission Academy officially opens

Estimates suggest that 40% of eczema flares are treated with topical antibiotics, but findings from a study led by Cardiff University suggest there is no meaningful benefit from the use of either oral or topical antibiotics for milder clinically infected eczema in children (Cardiff University, 2017). Eczema affects around one in five children in the … Continue reading No meaningful benefit using antibiotics for mildly infected eczema in children

Research at Swansea University could help predict further attacks and detect problems in heart attack patients (BBC News, 2017). Scientists have analysed a cell found in heart scar tissue which could cause increased risk of cardiac arrest. Myofibroblasts cells in patients might increase the likelihood of an electrical “short circuit”. Professor Chris George said “Cells … Continue reading Swansea University research could predict further heart attacks

Despite progress in understanding the genetics of rare childhood epilepsies, the common adult forms of epilepsy have proven less amenable to traditional gene-discovery analyses (Swansea University, 2017). The Epi4K consortium of experts, which includes academics from Swansea University, decided to assess the contribution of genome-wide ultra rare genetic variation in the common epilepsies. The results … Continue reading Swansea University scientists take part in largest study into the genetics of common epilepsy

A new Health and Wellbeing Academy which aims to give people more support to lead healthier lives is being officially opened today by Wales’ Health Secretary Vaughan Gething (WalesOnline, 2017). The academy offers a range of services, complementing those already being provided by the NHS. It includes an audiology department which provides hearing tests and … Continue reading Innovative new Health and Wellbeing Academy opens at Swansea University

Acerchem International, a leading Chinese health and nutraceutical group, is to establish its European HQ and R&D and manufacturing centre at the Institute of Life Sciences (ILS) at Swansea University (Welsh Government, 2017). The news was announced by Welsh Economy Secretary Ken Skates who is in China on a trade mission and has met with … Continue reading Acerchem International opening new R&D centre at Swansea University

BHF Cymru are investing £2.3m in research at Swansea University to help reduce the number of premature deaths in young people (Swansea University, 2017). It is estimated that one person every fortnight aged under thirty five in Wales is a victim of sudden cardiac death with seemingly no explanation, largely due to undiagnosed inherited heart … Continue reading Research aims to reduce premature deaths in young people

The National Research Network in Advanced Engineering and Materials (NRN AEM), an engineering network set up as part of the Welsh Government’s Science for Wales initiative, has been a significant support in aiding scientists to secure EU investments into Welsh universities (Business News Wales, 2017). Two projects funded as part of the NRN AEM have … Continue reading Welsh universities secure EU funding for the diagnosis and treatment of life threatening diseases

A British Heart Foundation Cymru funded research team led by Professor Alan Williams will be based at Swansea University Medical School from this month (Swansea University, 2017).‌ Swansea University Medical School will offer the opportunity for Alan Williams and his team to continue their unprecedented research in Wales with £2.3m of investment from BHF, after … Continue reading £2.3m BHF Cymru research hosted by Swansea University Medical School